SCHEMBL4010865

SCHEMBL4010865

Cc1cc(OBOc2ccc(OC(C)C)c(C)c2)ccc1OC(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
TSHR P16473 2/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
ALDH1A1 P00352 3/20 0.34
CSNK2A1 P68400 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SENP2 Q9HC62 1/20 0.34
SENP1 Q9P0U3 1/20 0.34
FFAR4 Q5NUL3 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALDH1A3 P47895 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16606251 0.84 ALDH1A1 (0.46) TDP1TSHRHTR2AHTR2CHTR2B
SCHEMBL1911936 0.81 CA12 (0.48) HTR2AALDH1A1KDM4EMAPTKMT2A
SCHEMBL4012282 0.80 CSNK2A1 (0.51) CSNK2A1KDM4EKMT2A
SCHEMBL2575428 0.80 KCNQ3 (0.36) ALDH1A1CSNK2A1HPGDFFAR4IRAK4
SCHEMBL23744 0.79 CA12 (0.45) ALDH1A1KDM4EMAPTKMT2ASMN1; SMN2
SCHEMBL16955559 0.76 NQO1 (0.45) TDP1TSHRALDH1A1KDM4EHPGD
SCHEMBL16955239 0.75 PPARD (0.41) FFAR4CYP1A2
SCHEMBL28111658 0.75 ALDH1A3 (0.42) TDP1TSHRHTR2AHTR2CHTR2B
SCHEMBL2997372 0.75 KCNK3 (0.39) CSNK2A1
SCHEMBL3659032 0.74 ESR1 (0.43) TDP1TSHRALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed
EP-2074117-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-01 EP disclosed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO disclosed